Recent advances in the regulation of cytosolic phospholipase A2

Advances in Enzyme Regulation

Volumn 40, Issue 1, 2000, Pages 255-268

  Gijón, Miguel A ^a   Spencer, Diane M ^a   Leslie, Christina C ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ICOSANOID; PHOSPHOLIPASE A; PHOSPHOLIPASE A2;

ANIMAL; ANIMAL CELL; CONFERENCE PAPER; CYTOSOL; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYMOLOGY; GENETICS; LIPID PEROXIDATION; METABOLISM; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SITE DIRECTED MUTAGENESIS;

ANIMALIA; MURINAE;

EID: 0034130439     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(99)00031-X     Document Type: Conference Paper

References (63)

1. 2, Crit. Rev. Immunol. 17, 225-283 (1997).
2. 2 superfamily of signal transduction enzymes, Trends Biochem. Sci. 22, 1-2 (1997).
3. 2, Semin. Cell Dev. Biol. 8, 297-303 (1997).
4. 2, J. Lipid Mediat. Cell Signal. 12, 83-117 (1995).
5. 2, J. Biol. Chem. 272, 16,709-16,712 (1997).
6. 2 activation, J. Leukoc. Biol. 65, 330-336 (1999).
7. 2 reveals a novel topology and catalytic mechanism, Cell 97, 349-360 (1999).
8. 2 to the nuclear fraction upon macrophage activation, Biochem. Biophys. Res. Commun. 196, 147-153 (1993).
9. 2 to the nuclear envelope and endoplasmic reticulum, J. Biol. Chem. 270, 30,749-30,754 (1995).
10. 2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen, J. Biol. Chem. 270, 15,359-15,367 (1995).
11. 2, J. Biol. Chem. 274, 5163-5169 (1999).
12. 2, J. Cell Biol. 145, 1219-1232 (1999).
13. 2, J. Biol. Chem. 274, 14,979-14,987 (1999).
14. J. W. WOODS, J. F. EVANS, D. ETHIER, S. SCOTT, P. J. VICKERS, L. HEARN, J. A. HEIBEIN, S. CHARLESON and I. I. SINGER, 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes, J. Exptl. Med. 178, 1935-1946 (1993).
15. I. MORITA, M. SCHINDLER, M. K. REGIER, J. C. OTTO, T. HORI, D. L. DEWITT and W. L. SMITH, Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2, J. Biol. Chem. 270, 10,902-10,908 (1995).
16. 2 is phosphorylated and activated by MAP kinase, Cell 72, 269-278 (1993).
17. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C, J. Biol. Chem. 268, 1960-1964 (1993).
18. 2 phosphorylation and eicosanoid production by colony-stimulating factor 1, J. Biol. Chem. 269, 31,693-31,700 (1994).
19. 2 in regulating arachidonic acid release in macrophages, J. Biol. Chem. 273, 8203-8211 (1998).
20. 2 activation by phosphorylation in mouse peritoneal macrophages, J. Biol. Chem. 268, 24,506-24,513 (1993).
21. 2 expressed in insect cells and present in human monocytes, J. Biol. Chem. 271, 6987-6997 (1996).
22. 2 and activation in mouse peritoneal macrophages, J. Biol. Chem. 270, 20,439-20,446 (1995).
23. 1 cells, J. Biol. Chem. 268, 21,875-21,882 (1993).
24. 1 macrophages, J. Biol. Chem. 271, 32,381-32,384 (1996).
25. 2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis, J. Biol. Chem. 269, 25,999-26,005 (1994).
26. 1 macrophages, J. Biol. Chem. 272, 29,317-29,321 (1997).
27. R. W. WAGNER, Gene inhibition using antisense oligodeoxynucleotides, Nature 372, 333-335 (1994).
28. A. D. BRANCH, A good antisense molecule is hard to find, Trends Biochem. Sci. 23, 45-50 (1998).
29. 2) in thrombin-stimulated platelets, J. Biol. Chem. 271, 27,723-27,729 (1996).
30. 2 and the release of arachidonic acid in human neutrophils, J. Immunol. 162, 2334-2340 (1999).
31. 2 in allergic response and parturition, Nature 390, 618-622 (1997).
32. 2, Nature 390, 622-625 (1997).
33. 2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells, Proc. Natl. Acad. Sci. U.S.A. 96, 4803-4807 (1999).
34. 2) by thrombin and thrombin receptor agonist peptide in human platelets, J. Biol. Chem. 270, 14,816-14,823 (1995).
35. 2 in agonist-stimulated human platelets and HeLa cells, J. Biol. Chem. 273, 4449-4458 (1998).
36. 2 in macrophages, Biochem. J. 325, 405-410 (1997).
37. 4 secretion by fluticasone propionate in exogenously activated human eosinophils, Am. J. Respir. Crit. Care Med. 159, 1903-1909 (1999).
38. 2, J. Biol. Chem. 273, 1365-1372 (1998).
39. 2, J. Biol. Chem. 273, 1596-1604 (1998).
40. 2, J. Mol. Biol. 280, 485-500 (1998).
41. S. CORBALÁN-GARCíA, J. A. RODRíGUEZ-ALFARO and J. C. GÓMEZ-FERNÁNDEZ, Determination of the calcium-binding sites of the C2 domain of protein kinase Cα that are critical for its translocation to the plasma membrane, Biochem. J. 337, 513-521 (1999).
42. 2+-dependent plasma membrane localization, J. Biol. Chem. 272, 32,329-32,336 (1997).
43. 2, Biochemistry 37, 8516-8526 (1998).
44. 2 from macrophages and reduce the calcium requirement for activity, Biochim. Biophys. Acta 1045, 261-270 (1990).
45. 2 binds with high affinity and specificity to phosphatidylinositol 4,5-bisphosphate resulting in dramatic increases in activity, J. Biol. Chem. 273, 2184-2191 (1998).
46. M. C. SEEDS and D. A. BASS, Regulation and metabolism of arachidonic acid, Clin. Rev. Allergy Immunol. 17, 5-25 (1999).
47. 2 during apoptosis, J. Immunol. 161, 5687-5694 (1998).
48. 2, which undergoes proteolytic inactivation, J. Biol. Chem. 273, 13,870-13,877 (1998).
49. 2 by caspase-1 (ICE) and caspase-8 (FLICE), Biochem. Biophys. Res. Commun. 253, 92-98 (1998).
50. R. BøE, B. T. GJERTSEN, O. K. VINTERMYR, G. HOUGE, M. LANOTTE and S. O. DøSKELAND, The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells, Exptl. Cell Res. 195, 237-246 (1991).
51. A. H. SCHÖNTHAL, Role of PP2A in intracellular signal transduction pathways, Front. Biosci. 3, 1262-1273 (1998).
52. 2+ signaling in smooth muscle by cAMP-and cGMP-dependent protein kinases, J. Biol. Chem. 273, 34,519-34,526 (1998).
53. 2 by annexin V in differentiated permeabilized HL-60 cells, J. Biol. Chem. 272, 10,474-10,482 (1997).
54. 2 by human annexin V, Biochem 329, 369-372 (1998).
55. 2 activity, Brit. J. Pharmacol. 124, 1675-1683 (1998).
56. 2 activity, J. Biol. Chem. 274, 17,202-17,208 (1999).
57. 2 is coupled to muscarinic receptors in the human astrocytoma cell line 1321N1: characterization of the transducing mechanism, Biochem. J. 323, 281-287 (1997).
58. iα-type G-protein, Biochim. Biophys. Acta 1341, 223-237 (1997).
59. i2α gene, Biochem. J. 332, 263-271 (1998).
60. 2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate, FEBS Lett. 450, 39-43 (1999).
61. 2 is required for the formation of interferon-stimulated gene factor three, EMBO J. 15, 1566-1571 (1996).
62. 2, J. Leukoc. Biol. 64, 221-227 (1998).
63. 2 activity: membrane effects versus enzyme phosphorylation, Arch. Biochem. Biophys. 343, 44-54 (1997).